A landmark study helps explain why Big Pharma is so afraid of the medical benefits of cannabis.
TÍMAMÓTA RANNSÓKN ÚTSKÝRIR HVERSVEGNA LYFJARISARNIR ERU SVONA HRÆDDIR VIÐ LÆKNINGA MÁTT KANNABIS. RANNSÓKNIN SEM UMRÆÐIR STYÐUR ÞÁ HUGMYND AÐ KANNABIS GETI VERIÐ NOTAÐ SEM NÁTTÚRULEGUR VALKOSTUR Á MÓTI UPPÁSKRIFUÐUM VERKJALYJUM, MEÐ NÆRRI 100% AF SVARENDA AÐ ÞEIM FYNDIST KANNABIS HJÁLPA TIL VIÐ AÐ MINNKA NOTKUN ÞEIRRA Á MORFÍN SKYLDUM LYJUM VIÐ VERKJUM.
The recent study is lending credibility to the idea that medical cannabis can be used as a natural alternative to prescription pain medications, with nearly 100 percent of respondents saying they believe cannabis is helping them decrease their use of prescription opioids to treat the pain.
The pharmaceutical and alcohol industries, both powerful influences in Washington, have long lobbied against cannabis legalization in order to protect their profits.
Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report
If medical cannabis was legalized in all 50 states, it would take at least $4.5 billion away from the stranglehold that has been established by big pharma.
The Undeniable Benefits of Medical Cannabis
Pharmaceuticals in general are among the leading causes of death in the US,
and some medicines have killed tens of thousands of individuals. The painkiller Vioxx
is one classic example, which killed over 60,000 before being pulled off the market.
The diabetes drug Avandia is another, and most recently, a study estimated that in a five-year span, some 800,000 people in Europe were killed from inappropriate use of beta-blockers in non-cardiac surgery patients. Deaths attributed to cannabis barely registers in comparison.